Gloyn noted that large amounts of genetic data from clinical trials likely already exist and could help answer important questions about why some people respond poorly to GLP-1 therapies
The absence of head-to-head data means the combination remains in the realm of clinical hypothesis rather than validated practice
Mostly after eating high tyrosine foods, although there are other triggers
approvals for injectable Zepbound and Wegovy were based on separate trials in which the Lilly drug helped patients lose more than 22% of their weight after 72 weeks, while Wegovy led to 15% weight loss after 68 weeks
These mechanisms have been demonstrated primarily in laboratory and animal studies
Wang Q, Chen W, Zhang B, Gao Z, Zhang Q, Deng H, et al